SLC38A2 and Glutamine Signaling in cDC1s Dictate Anti-Tumor Immunity

Researchers established glutamine as an intercellular metabolic checkpoint that dictated tumor–type-1 conventional dendritic cell crosstalk, and licensed their function in activating cytotoxic T cells.